Conrad P Earnest1, Steven N Blair, Timothy S Church. 1. Pennington Biomedical Research Center, Preventive Medicine and Exercise Biology, Louisiana State University System, Baton Rouge, Louisiana 70808, USA. conrad.earnest@pbrc.edu
Abstract
BACKGROUND: Our group has shown a positive dose-response in maximal cardiorespiratory exercise capacity (VO(2max)) and heart rate variability (HRV) to 6 months of exercise training but no improvement in VO(2max) for women ≥60 years. Here, we examine the HRV response to exercise training in postmenopausal women younger and older than 60 years. METHODS: We examined 365 sedentary, overweight, hypertensive, postmenopausal women randomly assigned tosedentary control or exercise groups exercising at 50% (4 kcal/kg/week, [KKW]), 100% (8 KKW) and 150% (12 KKW) of the National Institutes of Health (NIH) Consensus Development Panel physical activity guidelines. Primary outcomes included time and frequency domain indices of HRV. RESULTS: Overall, our analysis demonstrated a significant improvement in parasympathetic tone (rMSSD and high frequency power) for both age strata at 8 KKW and 12 KKW. For rMSSD, the age-stratified responses were: control, <60 years, 0.20 ms, 95% confidence interval (CI)-2.40, 2.81; ≥60 years, 0.07 ms, 95% CI -3.64, 3.79; 4 KKW, <60 years, 3.67 ms, 95% CI 1.55, 5.79; ≥60 years, 1.20 ms, 95% CI -1.82, 4.22; 8-KKW, <60 years, 3.61 ms, 95% CI 0.88, 6.34; ≥60 years, 5.75 ms, 95% CI 1.89, 9.61; and 12-KKW, <60 years, 5.07 ms, 95% CI 2.53, 7.60; ≥60 years, 4.28 ms, 95% CI 0.42, 8.14. CONCLUSIONS:VO(2max) and HRV are independent risk factors for cardiovascular disease (CVD) mortality. Despite no improvement in VO(2max), parasympathetic indices of HRV increased in women ≥60 years. This is clinically important, as HRV has important CVD risk and neurovisceral implications beyond cardiorespiratory function.
RCT Entities:
BACKGROUND: Our group has shown a positive dose-response in maximal cardiorespiratory exercise capacity (VO(2max)) and heart rate variability (HRV) to 6 months of exercise training but no improvement in VO(2max) for women ≥60 years. Here, we examine the HRV response to exercise training in postmenopausal women younger and older than 60 years. METHODS: We examined 365 sedentary, overweight, hypertensive, postmenopausal women randomly assigned to sedentary control or exercise groups exercising at 50% (4 kcal/kg/week, [KKW]), 100% (8 KKW) and 150% (12 KKW) of the National Institutes of Health (NIH) Consensus Development Panel physical activity guidelines. Primary outcomes included time and frequency domain indices of HRV. RESULTS: Overall, our analysis demonstrated a significant improvement in parasympathetic tone (rMSSD and high frequency power) for both age strata at 8 KKW and 12 KKW. For rMSSD, the age-stratified responses were: control, <60 years, 0.20 ms, 95% confidence interval (CI)-2.40, 2.81; ≥60 years, 0.07 ms, 95% CI -3.64, 3.79; 4 KKW, <60 years, 3.67 ms, 95% CI 1.55, 5.79; ≥60 years, 1.20 ms, 95% CI -1.82, 4.22; 8-KKW, <60 years, 3.61 ms, 95% CI 0.88, 6.34; ≥60 years, 5.75 ms, 95% CI 1.89, 9.61; and 12-KKW, <60 years, 5.07 ms, 95% CI 2.53, 7.60; ≥60 years, 4.28 ms, 95% CI 0.42, 8.14. CONCLUSIONS: VO(2max) and HRV are independent risk factors for cardiovascular disease (CVD) mortality. Despite no improvement in VO(2max), parasympathetic indices of HRV increased in women ≥60 years. This is clinically important, as HRV has important CVD risk and neurovisceral implications beyond cardiorespiratory function.
Authors: Bernard Gutin; Cheryla Howe; Maribeth H Johnson; Matthew C Humphries; Harold Snieder; Paule Barbeau Journal: Med Sci Sports Exerc Date: 2005-11 Impact factor: 5.411
Authors: Chin K Kim; Susan P McGorray; Beth A Bartholomew; Michelle Marsh; Tammy Dicken; Sylvia Wassertheil-Smoller; J David Curb; Albert Oberman; Judith Hsia; Julius Gardin; Nathan D Wong; Bruce Barton; Robert P McMahon; David S Sheps Journal: Arch Intern Med Date: 2005-06-13
Authors: Dae Hyun Kim; Lewis A Lipsitz; Luigi Ferrucci; Ravi Varadhan; Jack M Guralnik; Michelle C Carlson; Lee A Fleisher; Linda P Fried; Paulo H M Chaves Journal: J Am Geriatr Soc Date: 2006-11 Impact factor: 5.562
Authors: Marianne P da C de Rezende Barbosa; Luiz C M Vanderlei; Lucas M Neves; Carolina Takahashi; Paula R Dos S Torquato; Ana Claúdia de S Fortaleza; Ismael F Freitas Júnior; Isabel C E Sorpreso; Luiz C Abreu; Andrés R Pérez Riera Journal: Ann Noninvasive Electrocardiol Date: 2017-07-25 Impact factor: 1.468
Authors: Janine Giese-Davis; Frank H Wilhelm; Rie Tamagawa; Oxana Palesh; Eric Neri; Craig Barr Taylor; Helena C Kraemer; David Spiegel Journal: Psychosom Med Date: 2015-05 Impact factor: 4.312